Ascletis Pharma Inc. ASCLF OTC

Ascletis Pharma Inc. (ASCLF) reported total assets of $2B and total liabilities of $129M for quarter ending 2025-06-30, resulting in total equity of $1.87B.

The company held $1.8B in cash and short-term investments. Total debt stood at $4.27M, with net debt of $-1.58B. The Debt-to-Equity (D/E) ratio was 0 (conservative).

Current ratio is 14.57, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (62/100) — Total assets $2B and equity $1.87B support the company's competitive scale

Overall SharesGrow Score: 29/100 with 0/7 criteria passed.